SeaSpine Reports 21 Percent Revenue Growth for First Quarter 2022 and Increases Full Year 2022 Revenue Guidance
May 03, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces New Senior Leadership Team Appointments
May 03, 2022 16:04 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families
May 02, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces Full Commercial Launch of Explorer® TO Expandable Interbody System
April 28, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Report First Quarter 2022 Financial Results on May 3, 2022
April 19, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Announces Full Commercial Launch of the Reef® TA (TLIF Articulating) Interbody System
April 11, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces 50,000th NanoMetalene® Implantation
March 24, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Participate in the Canaccord Musculoskeletal Conference
March 15, 2022 09:00 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results
March 11, 2022 09:00 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., March 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces New Senior Leadership Team Appointments
March 07, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...